Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer

Journal of Cancer Research and Clinical Oncology
Qi HuangYang Jin

Abstract

Retinoic acid-related orphan receptor C isoform 2 (RORC2) is regarded as a pathogenic factor for autoimmune and inflammatory diseases and tumours. Previous studies have primarily focused on RORC2 expression in IL-17-producing immune cells but not in carcinoma cells; thus, little is known about the roles of RORC2 in the progression of human non-small cell lung cancer (NSCLC). In this study, we analysed the expression of RORC2 and its participation in tumour progression in NSCLC. RORC2 expression in NSCLC and adjacent normal lung tissues was assessed via quantitative real-time PCR (qRT-PCR) and immunohistochemistry. RORC2 expression in NSCLC cell lines was examined by qRT-PCR, Western blotting and flow cytometry. The effects of inhibiting RORC2 activity on the proliferation of NSCLC cells were evaluated. The prognostic value of RORC2 for NSCLC was revealed based on Kaplan-Meier analysis. High RORC2 expression was observed in lung cancer tissues and was significantly related to age (p = 0.013) and regional lymph node metastasis (p = 0.009). RORC2 expression was higher in the A549, H460, SPC-A1 and H1299 cell lines than in a control cell line. In addition, cell proliferation was decreased in NSCLC cells upon the blocking of RORC2 a...Continue Reading

References

Jul 9, 1999·Immunology Letters·F PagesW H Fridman
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·S KurebayashiA M Jetten
Jun 13, 2001·Biochemical and Biophysical Research Communications·T KatoT Aono
Aug 12, 2004·International Journal of Cancer. Journal International Du Cancer·Arnaud CiréeEric Tartour
Oct 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Muneo NumasakiHidetada Sasaki
Jan 31, 2009·The Journal of Allergy and Clinical Immunology·Simone BurglerCarsten B Schmidt-Weber
May 6, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shuta TomidaTakashi Takahashi
May 14, 2009·Journal of the National Cancer Institute·Maggie C U CheangTorsten O Nielsen
Jun 6, 2009·European Journal of Immunology·Derya Unutmaz
Dec 22, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Xi ChenZhengtang Chen
Jan 29, 2010·Seminars in Immunopathology·Keiji HirotaMarc Veldhoen
Apr 30, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Simone BurglerCarsten B Schmidt-Weber
Sep 29, 2011·PloS One·Sophie KirshbergOri Wald
Feb 2, 2012·ACS Chemical Biology·Naresh KumarPatrick R Griffin
May 19, 2012·Current Opinion in Immunology·Christoph S N KloseAndreas Diefenbach
Jun 16, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelElizabeth Ward
Jul 10, 2012·Nature Medicine·Rahul PurwarThomas S Kupper
Jul 14, 2012·Molecular and Cellular Endocrinology·Michele VaccaAntonio Moschetta
Oct 24, 2012·Immunology Letters·Qinchuan LiZhongmin Liu
Jun 19, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sebastian KoboldStefan Endres
Sep 17, 2013·Zhongguo fei ai za zhi = Chinese journal of lung cancer·Gaiping HeLingling Xu
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 25, 2014·Thyroid : Official Journal of the American Thyroid Association·Michael MondChristopher Gilfillan
Mar 29, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrzej T SlominskiAnton M Jetten
Apr 1, 2014·FEBS Letters·Sascha CordingGérard Eberl

❮ Previous
Next ❯

Citations

Jun 30, 2016·Expert Opinion on Therapeutic Targets·Markus JoergerSteven G Gray
Sep 22, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Jian LiZijian Wang
Jun 16, 2018·Frontiers in Immunology·Jinshuo FanYang Jin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Hong LiJianping Xu
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Ning SongCong-Min Zhang
© 2021 Meta ULC. All rights reserved